CTOs on the Move

Acucela

www.acucela.com

 
Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases impacting millions of individuals worldwide. Acucela currently has the following candidates in development with Otsuka Pharmaceutical: emixustat hydrochloride for GA associated with dry AMD based on Acucela’s proprietary visual cycle modulation; and OPA-6566 for ocular hypertension and glaucoma.
  • Number of Employees: 100-250
  • Annual Revenue: $1-10 Million
  • www.acucela.com
  • 1301 2nd Ave # 1900
    Seattle, WA USA 98101
  • Phone: 206.805.8300

Executives

Name Title Contact Details

Similar Companies

Primaris

Primaris is a Columbia, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

GRO Biosciences

GRO Biosciences transforms protein therapeutics with new amino acid building blocks to treat incurable diseases.

Sunrider

Sunrider offers an extraordinary opportunity to own a franchise-like business for a minimal cost. We have invested hundreds of millions of dollars in our global operations to provide you with exceptional support. We research, develop, and manufacture high quality herbal products in our 2 million square foot state-of-the-art manufacturing facilities.

Silverado Senior Living

Silverado Senior Living is a Redondo Beach, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

VisualMED Clinical Solutions

VisualMED Clinical Solutions Corp. is a Outremont, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.